News Updates
We found these articles on Alzheimer’s, Parkinson’s, Multiple Sclerosis, Dementia (Lewy Body, Vascular, Frontotemporal), aging, loneliness, brain health, loneliness and caregiving to be useful. We hope you do too.
We also post a lot of articles on Twitter, LinkedIn and Facebook, so you might find it very informative and helpful to follow us there as well. And lastly, you can sign-up for our Weekly Newsletter
Curated Articles
We have been sharing news via various social media channels for the last couple of years, but have decided to build a collection of those that are most relevant in one curated list for your convenience.
Alzheimer’s Disease
F.D.A. Panel Declines to Endorse Controversial Alzheimer’s Drug
Nov, 6, 2020
The drug, aducanumab, made by Biogen, would be the first new Alzheimer’s treatment in nearly two decades. But the advisory panel said there was not enough evidence of its effectiveness in slowing cognitive decline.
Alzheimer’s Disease
Biogen’s Aducanumab Alzheimer’s Drug Treatment Review by FDAS
Aug. 6, 2020
Biogen’s controversial Aducanumab drug treatment for Alzheimer’s Disease has just been accepted for review by the FDA. Approval may come as early as March 2021. Though results are controversial, the FDA may feel pressure to approve Aducanumab in the absence of any other treatment.
Alzheimer’s Disease
New Blood Test May Detect Alzheimer’s 10-20 Years Earlier
Apr. 6, 2020
A new method for detecting Alzheimer’s Disease could give early warning 10-20 year before symptoms begin to manifest, giving the opportunity to treat and slow the disease far early than today.
Alzheimer’s Disease
Widowhood increases risk of Alzheimer’s, study says
Feb. 26, 2020
Losing your spouse or life partner and gaining the designation “widow” or “widower” is one of life’s cruelest blows. Now science believes that widowhood may hasten the development of a type of cognitive decline associated with Alzheimer’s.
Alzheimer’s Disease
Cut Out Alzheimer’s Gene in Mice, Study Shows
Feb. 14, 2020
Using the gene editing technology CRISPR-Cas9 like a pair of “DNA scissors,” researchers were able to essentially cut out the beta-secretase 1 (BACE1) gene in a mouse model of Alzheimer’s disease.
Alzheimer’s Disease
Newly Discovered Gene Hints at Possible Breakthrough for Alzheimer’s Disease
Jan. 23, 2020
Investigators at the Case Western Reserve University School of Medicine identified a previously unknown gene and the resultant protein that may potentially slow the progress of Alzheimer’s disease.
Alzheimer’s Disease
What causes Alzheimer’s? Not toxic amyloid, new study suggests
Jan. 4, 2020
Many researchers have argued that the accumulation of toxic beta-amyloid in the brain causes Alzheimer’s. However, a new study offers some evidence contradicting this sequence.
Alzheimer’s Disease
New Alzheimer’s Drug from China: Hope or Hype?
Nov. 5, 2019
A Chinese drugmaker has stunned the world with news that it has won conditional approval from the Chinese equivalent of the FDA to sell a new drug for Alzheimer’s disease.
Parkinson’s Disease
Concussion Linked with 57% Higher Risk for Parkinson’s
Aug. 4,, 2020
People who had a concussion are more likely to be diagnosed later in life with Parkinson’s disease and other neurologic disorders than those who never had this type of brain injury, a database study reports.
Parkinson’s Disease
How to Detect Parkinson’s Disease
Feb. 12,, 2020
The Holy Grail in any progressive disease is to find it early enough to start effective treatment before irreversible damage has occurred. But recognizing the early warning signs of Parkinson’s disease is challenging because they’re usually subtle and can be easily overlooked, dismissed or even misdiagnosed.
Parkinson’s Disease
Molecular switch for repairing central nervous system disorders
Jan. 10,, 2020
A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), researchers have discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system.
Multiple Sclerosis
Molecular switch for repairing central nervous system disorders
Jan. 10, 2020
A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), researchers have discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system.
Dementia
Could some antibiotics help treat early onset dementia?
Jan. 14, 2020
The symptoms of frontotemporal, or early onset, dementia can appear as early as age 40. Have researchers found a new way to treat this condition using antibiotics?
Dementia
Vaccine for dementia to enter human trials after successful tests on mice
Jan. 1, 2020
‘This could be revolutionary,’ says lead researcher as treatment found to remove causes of brain decline
A vaccine designed to prevent dementia is to enter human trials after successful tests on mice.
If the treatment is proven to work safely on people it could be available within a decade, researchers say.
The revelation, published in the journal Alzheimer’s Research & Therapy, comes after 20 years of research backed by the US government and largely carried out in Australia.
Aging
What The 2020s Have In Store For Aging Boomers
Jan. 16, 2020
Within 10 years, all of the nation’s 74 million baby boomers will be 65 or older. The most senior among them will be on the cusp of 85.
Even sooner, by 2025, the number of seniors (65 million) is expected to surpass that of children age 13 and under (58 million) for the first time, according to Census Bureau projections.
Aging
Everyone Knows Memory Fails as You Age. But Everyone Is Wrong.
Jan. 10, 2020
Short-term memory is easily disturbed or disrupted. It depends on your actively paying attention to the items that are in the “next thing to do” file in your mind. You do this by thinking about them, perhaps repeating them over and over again (“I’m going to the closet to get gloves”). But any distraction — a new thought, someone asking you a question, the telephone ringing — can disrupt short-term memory. Our ability to automatically restore the contents of the short-term memory declines slightly with every decade after 30.
But age is not the major factor so commonly assumed. I’ve been teaching undergraduates for my entire career and I can attest that even 20-year-olds make short-term memory errors — loads of them.
Aging
What to know about CoQ10 and its dosage
Dec. 3, 2019
Coenzyme Q10, or CoQ10, is a naturally occurring chemical that exists in almost every cell of the human body. CoQ10 carries out several vital roles, including promoting energy production and neutralizing harmful particles called free radicals.
A deficiency in CoQ10 can adversely affect a person’s health. People can get CoQ10 through foods and supplements.
Caregiving
Family Caregivers Are Rarely Asked About Needing Assistance With Caring for Older Adults
Jan. 22, 2020
A recent study suggests that we as a society could do a better job of supporting family caregivers, who are providing the lion’s share of day-to-day care to older adults with activity limitations. No surprise there! #caregiver
Brain Health
Why we underestimate the burden of stress on employees
Jan. 23, 2020
Prolonged periods of emotional or physical stress lead to depression, anxiety, loss of sleep, memory loss, and cognitive impairment; not to mention physical ailments affecting weight, heart disease, and the autoimmune system.
Brain Health
Could hydration levels influence cognitive function?
Jan. 5, 2020
Dehydration can cause headaches and several physiological issues, and older adults are most at risk of experiencing it. Does it also affect cognitive function, however? And might overhydration also affect mental performance?
Brain Health
Losing Even Just One Night of Sleep May Trigger Alzheimer’s Biomarker
Jan. 5, 2020
Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According to a new small study, losing just one night of sleep may increase a biomarker associated with Alzheimer’s disease.